Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    - The page shows additions and deletions of date strings (e.g., 2025-12-23, 2025-12-04, 2025-12 and 2025-11-13, 2025-11-06, 2025-11), which appear to be update timestamps rather than alterations to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-27T23:09:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a new Locations section with an expanded list of study sites (Arizona, California, Colorado, Florida, Georgia, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Jersey, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Ontario, Quebec) and updated to Revision: v3.3.3; removed the prior per-state location subsections such as 'Arizona Locations' and 'California Locations'.
    Difference
    0.6%
    Check dated 2025-12-20T21:05:28.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated from v3.3.1; no substantive study information is affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-29T03:14:18.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    PubMed auto-fill clarification and a new Revision: v3.3.1 have been added to the Publications section. The previous PubMed auto-fill description and Revision: v3.2.0 text were removed.
    Difference
    0.0%
    Check dated 2025-11-22T02:25:52.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a new trial site in Tainan, Taiwan (704) on 2025-11-13, with related updates on 2025-11-06 and 2025-11.
    Difference
    0.2%
    Check dated 2025-11-14T21:20:08.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Added a new NEJM publication entry for MARIPOSA: Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC (N Engl J Med, Oct 30, 2025; DOI: 10.1056/NEJMoa2503001; Epub Sep 7, 2025). Removed the previous 'Online ahead of print' listing for the same article (Sept 7, 2025).
    Difference
    0.0%
    Check dated 2025-11-07T15:13:48.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.